Resistance to EGFR inhibitors: Molecular determinants and the enigma of head and neck cancer

Oncotarget

Volumn 2, Issue 12, 2011, Pages 894-895

  Morris, Luc G T ^a   Chan, Timothy A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY; PROTEIN KINASE INHIBITOR; PTPRS PROTEIN, HUMAN; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE;

DRUG ANTAGONISM; EDITORIAL; GENE DELETION; GENETICS; HEAD AND NECK TUMOR; HUMAN; METABOLISM; SQUAMOUS CELL CARCINOMA;

ANTIBODIES, MONOCLONAL; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; PROTEIN KINASE INHIBITORS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 2; SEQUENCE DELETION;

EID: 84860328097     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.407     Document Type: Note

References (8)

1. Bonner JA, Harari PM, Giralt J et al. The Lancet Oncology. 2010; 11:21-28.
2. Vermorken JB, Trigo J, Hitt R et al. J Clin Oncol. 2007; 25:2171-2177.
3. Soulieres D, Senzer NN, Vokes EE et al. J Clin Oncol. 2004; 22:77-85.
4. Paez JG, Janne PA, Lee JC et al. Science. 2004; 304:1497-1500.
5. Lievre A, Bachet JB, Le Corre D et al. Cancer Res. 2006; 66:3992-3995.
6. Wheeler DL, Dunn EF, Harari PM. Nat Rev Clin Oncol. 2010; 7:493-507.
7. Hatakeyama H, Cheng H, Wirth P et al. PLoS One. 2010; 5:e12702.
8. Morris LG, Taylor BS, Bivona TG et al. Proc Natl Acad Sci U S A. 2011; 108:19024-19029.